
Steroid nasal sprays reduce COVID-related poor outcomes, study suggests
Fox News
Regular use of steroid nasal sprays afforded COVID-19 patients protection against virus-related hospitalization, ICU admission and death, the Cleveland Clinic announced Tuesday.
Researchers excluded patients who received INCS prescriptions prior to 2018, as well as pregnant women, those with missing hospitalization data and others.
Patients receiving the spray before COVID-19 illness faced a 22% lower likelihood of virus-related hospitalization, 23% lower odds of ICU admission and 24% reduced risk of COVID-related hospital death, versus patients not taking a steroid nasal spray, according to a release from the Cleveland Clinic.

Ancient silver cup may show world's oldest cosmic creation scene, researcher says: 'Chaos prevailed'
Researchers say they've discovered what may be the oldest depiction of cosmic creation. It appers on a 4,000-year-old silver cup found in a West Bank archaeological site.












